 |
| NFRX Issues Important News ADMD Enjoys Solid Day |
|
 Hot Stock to Watch
|
Company: InferX Corporation (Pink Sheets: NFRX)
|
End of Day:
Price: 0.05
Change (%): + 0.014 (38.89)
Volume: 32,516 |
 |
InferX Corporation Announces Alliance Agreement with e-Discovery/Technology Firm Crossfield Data Services; Michael Deale Appointed InferX Acting EVP
TYSONS CORNER, Va., Aug. 6, 2013 /PRNewswire/ - InferX Corporation (OTC/PK: NFRX) finalized a strategic alliance with Crossfield Data Services (“Crossfield”), a leading advanced data analytics and technical support firm offering litigation, compliance, and government investigations support for commercial and government clients. Under terms of the agreement, Crossfield will support InferX’s software development program and commercial launch of InferX’s analytics products and solutions; provide technical liaison support for InferX’s expanding teaming partners; provide communication infrastructure for inferX’s upcoming Financial Analytic Management Solutions (“FAMS”) cloud-based services; and, assist in developing new analytic solutions to meet emerging client needs. Under terms of the agreement, InferX is also granted first right of refusal for the next twelve (12) months to acquire Crossfield under terms subject to future negotiation.
Michael Deale, Crossfield President and a member of InferX’s Management Advisory Board, will join the InferX management team and serve as Acting Executive Vice President - Services and Marketing, overseeing management of all InferX technical development and business development activities.
Continue Reading
|
 Yesterday's Top Performer
|
Company: Advanced Medical Isotope Corp. (OTCQB: ADMD)
|
End of Day:
Price: 0.062
Change (%): + 0.012 (24.00)
Volume: 91,310 |
 |
Advanced Medical Isotope Corporation (AMIC) Mission employs innovative production methods to offer a wide range of reliable, domestically produced medical isotopes as well as in vivo delivery systems to aid medical practitioners and medical researchers in the timely diagnosis and effective treatment of diseases such as cancer, heart disease, neurological disorders, and many other medical conditions.
AMIC's Vision is to globally empower physicians, medical researchers, and ultimately, patients, by providing them with essential medical isotopes that, until now, have not been practical or economical to produce, in an effort to detect, manage, and cure human disease, and improve the lives of patients in the United States of America and worldwide.
Our Core Values are based on the simple things in life. Accountability. Management. Innovation. Commitment (AMIC). These are more than words to our organization. They are the foundation on that we are driven to create a legacy company, that will shape the future of patient care in this Millenium.
Company Information Sheet
|
Other Small Cap News
|
Company: Nuvilex Inc. (OTCQB: NVLX)
|
Nuvilex's Major Achievements Set Stage for Big 2014
BALTIMORE, MD--(Marketwired - Aug 6, 2013) - In a newly released research update, Goldman Small Cap Research, a stock market research firm focused on the small cap and microcap sectors, notes in a research update that Nuvilex Inc.'s (OTCQB: NVLX) just released shareholder update indicates that recent and pending milestones set the stage for a big 2014 for the Company. Nuvilex Inc. is an international firm engaged in live-cell encapsulation technology to treat pancreatic cancer along with the development and study of medical marijuana for use in oncology treatment.
Nuvilex owns exclusive worldwide rights to the live-cell encapsulation-based platform technology for any and all cancer types, including a pancreatic cancer treatment that successfully completed Phase II clinical trials. This platform, which essentially serves as an existing therapy booster, is based upon its live-cell encapsulation technology and delivery system and enhances the quality of life.
Continue Reading
|
Company: Amarantus BioScience Holdings, Inc. (OTCQB: AMBS)
|
Amarantus Issues Mid-Year President's Letter to Shareholders
SUNNYVALE, Calif., Aug. 6, 2013 (GLOBE NEWSWIRE) -- Amarantus BioScience Holdings, Inc. (OTCQB:AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated with neurodegeneration and apoptosis, today announced that its President and CEO Gerald Commissiong posted a mid-year President's Letter to shareholders.
Dear Shareholder,
We continue to make progress in our mission to bring new products to market to improve the health of patients suffering from disorders of the brain. In order to position the Company for significant growth in the second half of 2013, we spent the last few months making in-depth assessments of our two lead programs; LymPro Test® ("LymPro") diagnostic blood test for Alzheimer's disease, and MANF disease-modifying therapy for Parkinson's disease and other apoptosis-related disorders.
Continue Reading |
Market News
|
By Lee Brodie: CNBC
|
Cramer: 5 things that should be in your portfolio
As you put together your portfolio, Jim Cramer says include these 5 things; they should increase your chances of success.
"You need a dividend-paying stock with a high yield, you need a growth stock, you need something speculative, and you need something foreign and you need some gold," he said. That's right gold.
"As a general rule of thumb, when it comes to a high-octane secular grower, the stock can trade up to a multiple that's as high as twice the long-term growth rate before it gets too expensive for the vast majority of growth oriented money managers. So if the company's growing its earnings per share at a 20% clip, its stock could potentially fly as high as 40 times earnings," said Cramer.
Continue Reading
|
By Tami Luhby: CNNMoney.com
|
Where Obamacare Premiums Will Soar
Get ready to shell out more money for individual health insurance under Obamacare... in some states, that is.
While many residents in New York and California may see sizable decreases in their premiums, Americans in many places could face significant increases if they buy insurance through state-based exchanges next year.
That's because these people live in states where insurers were allowed to sell bare-bones plans and exclude the sick, which has kept costs down. Under Obamacare, insurers must offer a package of essential benefits -- including maternity, mental health and medications -- and must cover all who apply. But more comprehensive coverage may lead to more expensive insurance plans.
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the "unsubscribe" link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
